Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Martin-Villar

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Haemostasis|January 1, 1992
La Paz Hemophilia Center, 1967-1992: people, events, and memoriesJ Martin-Villar
Sangre|January 1, 1978
[Epidemiology, immunology, and methods for the detection of inhibitors in haemophilia (author's transl)]F Ortega, J Martin Villar, M Magallon
Thrombosis and Haemostasis|June 30, 1976
Management of hemophilia in SpainJ Martin-Villar, F Ortega, M Magallon
Sangre|January 1, 1979
[Clinical aspects and therapy of hemophilia. Introduction]J Martin Villar, F Ortega, M Magallón
Sangre|January 1, 1970
[Leukocyte antibodies and blood transfusion]M Magallon, J L Navarro, J Martin-Villar
Sangre|January 1, 1970
[Prophylaxis in hemophilia]F Ortega, J Martin-Villar, J L Navarro
Sangre|January 1, 1979
[Self treatment in hemophilia]M Magallón, J Martin Villar, F Ortega, et al.
British Journal of Haematology|July 1, 1991
Identification of a new haemophilia BM case produced by a mutation located at the carboxy terminal cleavage site of activation peptideJ Solera, M Magallón, J Martin-Villar, et al.
American Journal of Human Genetics|February 1, 1992
Factor IXMadrid 2: a deletion/insertion in factor IX gene which abolishes the sequence of the donor junction at the exon IV-intron d splice siteJ Solera, M Magallón, J Martin-Villar, et al.
Sangre|January 1, 1979
[Surgery in hemophilia]M Magallon, J Martin Villar, F Ortega, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Haemostasis|January 1, 1992
La Paz Hemophilia Center, 1967-1992: people, events, and memoriesJ Martin-Villar
Sangre|January 1, 1978
[Epidemiology, immunology, and methods for the detection of inhibitors in haemophilia (author's transl)]F Ortega, J Martin Villar, M Magallon
Thrombosis and Haemostasis|June 30, 1976
Management of hemophilia in SpainJ Martin-Villar, F Ortega, M Magallon
Sangre|January 1, 1979
[Clinical aspects and therapy of hemophilia. Introduction]J Martin Villar, F Ortega, M Magallón
Sangre|January 1, 1970
[Leukocyte antibodies and blood transfusion]M Magallon, J L Navarro, J Martin-Villar
Sangre|January 1, 1970
[Prophylaxis in hemophilia]F Ortega, J Martin-Villar, J L Navarro
Sangre|January 1, 1979
[Self treatment in hemophilia]M Magallón, J Martin Villar, F Ortega, et al.
British Journal of Haematology|July 1, 1991
Identification of a new haemophilia BM case produced by a mutation located at the carboxy terminal cleavage site of activation peptideJ Solera, M Magallón, J Martin-Villar, et al.
American Journal of Human Genetics|February 1, 1992
Factor IXMadrid 2: a deletion/insertion in factor IX gene which abolishes the sequence of the donor junction at the exon IV-intron d splice siteJ Solera, M Magallón, J Martin-Villar, et al.
Sangre|January 1, 1979
[Surgery in hemophilia]M Magallon, J Martin Villar, F Ortega, et al.
Pageof 3